Difference between revisions of "Lnc-NDST1-1:2"

From LncRNAWiki
Jump to: navigation, search
 
(4 intermediate revisions by 4 users not shown)
Line 2: Line 2:
  
 
==Annotated Information==
 
==Annotated Information==
 +
===Name===
 +
Alpha 250/ Alpha 280
 +
 +
===Characteristics===
 +
Two overlapping antisense RNAs from intron 1 of the human ribosomal protein 14 (Rps14) gene, identified by RNase Protection Assay (RPA).. RPA expression analysis using both cell extracts and cell-free transcription system indicates full-length sizes of 250 and 280 nt, respectively. Transcripts terminate at the same nucleotide, therefore alpha-250 overlaps alpha-280 along its whole length.. Transcription of both RNAs is resistant to high concentrations of RNAPII inhibitor alpha-amanitin.
 +
 +
===Function===
 +
Regulates RPS14 transcription.. Each lncRNA can interact with the Rps14 gene loci to stimulate its expression in-trans.. Each lncRNA is transcribed through a known enhancer with putative transcription factor binding abilities, suggesting the 'enhancer' may be the transcribed RNA, which could be recruiting transcription factors to the Rps14 gene.
 +
 +
===Expression===
 +
Ubiquitously expressed in the human tissues and cell lines examined. .  Alpha-250 was almost exclusively cytoplasmic. Alpha- 280 was mostly in the nucleus.
 +
 +
===Conservation===
 +
Please input conservation information here.
 +
 +
===Misc===
 +
Please input misc information here.
 +
 
===Transcriptomic Nomeclature===
 
===Transcriptomic Nomeclature===
 
Please input transcriptomic nomeclature information here.
 
Please input transcriptomic nomeclature information here.
 
===Function===
 
Please input function information here.
 
  
 
===Regulation===
 
===Regulation===
 
Please input regulation information here.
 
Please input regulation information here.
 
===Expression===
 
Please input expression information here.
 
  
 
===Allelic Information and Variation===
 
===Allelic Information and Variation===
Line 26: Line 38:
  
 
==References==
 
==References==
Please input cited references here.
+
[http://www.lncrnadb.org/alpha250alpha280/ Annotation originally sourced from lncRNAdb.]
  
 
{{basic|
 
{{basic|
Line 42: Line 54:
 
sequence = <dnaseq>GCCGTATTGCGGGGCCGAGGCCTTAAAAGGCTGGACCCGCACTCACCCTTACTTCACAAGCTCCTCCCTGAAAGCAAAACGGGCCTTCTGAGACCAGGAACGAACTCAATCCCGAGTTGGCCAGGATCCAGGTGGGCCAGCCGCGCGTCTCTTGCCCGGCACCTAGCTCGGTTCCCACGGAAAGACCCCCGTCTCTCGTCCCAAGCCCCACAGGGTCCCCTCGCCGCAGGATGCCCCCCGATTGTCGCGCCCGGGC</dnaseq>|
 
sequence = <dnaseq>GCCGTATTGCGGGGCCGAGGCCTTAAAAGGCTGGACCCGCACTCACCCTTACTTCACAAGCTCCTCCCTGAAAGCAAAACGGGCCTTCTGAGACCAGGAACGAACTCAATCCCGAGTTGGCCAGGATCCAGGTGGGCCAGCCGCGCGTCTCTTGCCCGGCACCTAGCTCGGTTCCCACGGAAAGACCCCCGTCTCTCGTCCCAAGCCCCACAGGGTCCCCTCGCCGCAGGATGCCCCCCGATTGTCGCGCCCGGGC</dnaseq>|
 
}}
 
}}
[[Category:Antisense]]
+
[[Category:Antisense]][[Category:lnc-NDST1-1]][[Category:Transcripts]]
 
 
{{lncrnadb|
 
tID = Lnc-NDST1-1:2|
 
ltID = Alpha 250/ Alpha 280|
 
ann = <tab class=wikitable sep=tab head=top>
 
Section Description
 
ID Alpha250
 
Characteristics Two overlapping antisense RNAs from intron 1 of the human ribosomal protein 14 (Rps14) gene, identified by RNase Protection Assay (RPA).. RPA expression analysis using both cell extracts and cell-free transcription system indicates full-length sizes of 250 and 280 nt, respectively. Transcripts terminate at the same nucleotide, therefore alpha-250 overlaps alpha-280 along its whole length.. Transcription of both RNAs is resistant to high concentrations of RNAPII inhibitor alpha-amanitin.
 
Expression Ubiquitously expressed in the human tissues and cell lines examined. .  Alpha-250 was almost exclusively cytoplasmic. Alpha- 280 was mostly in the nucleus.
 
Function Regulates RPS14 transcription.. Each lncRNA can interact with the Rps14 gene loci to stimulate its expression in-trans.. Each lncRNA is transcribed through a known enhancer with putative transcription factor binding abilities, suggesting the 'enhancer' may be the transcribed RNA, which could be recruiting transcription factors to the Rps14 gene.
 
</tab>|
 
}}
 

Latest revision as of 06:11, 26 August 2015

Please input one-sentence summary here.

Annotated Information

Name

Alpha 250/ Alpha 280

Characteristics

Two overlapping antisense RNAs from intron 1 of the human ribosomal protein 14 (Rps14) gene, identified by RNase Protection Assay (RPA).. RPA expression analysis using both cell extracts and cell-free transcription system indicates full-length sizes of 250 and 280 nt, respectively. Transcripts terminate at the same nucleotide, therefore alpha-250 overlaps alpha-280 along its whole length.. Transcription of both RNAs is resistant to high concentrations of RNAPII inhibitor alpha-amanitin.

Function

Regulates RPS14 transcription.. Each lncRNA can interact with the Rps14 gene loci to stimulate its expression in-trans.. Each lncRNA is transcribed through a known enhancer with putative transcription factor binding abilities, suggesting the 'enhancer' may be the transcribed RNA, which could be recruiting transcription factors to the Rps14 gene.

Expression

Ubiquitously expressed in the human tissues and cell lines examined. . Alpha-250 was almost exclusively cytoplasmic. Alpha- 280 was mostly in the nucleus.

Conservation

Please input conservation information here.

Misc

Please input misc information here.

Transcriptomic Nomeclature

Please input transcriptomic nomeclature information here.

Regulation

Please input regulation information here.

Allelic Information and Variation

Please input allelic information and variation information here.

Evolution

Please input evolution information here.

You can also add sub-section(s) at will.

Labs working on this lncRNA

Please input related labs here.

References

Annotation originally sourced from lncRNAdb.

Basic Information

Transcript ID

lnc-NDST1-1:2

Source

LNCipedia2.1

Same with

,

Classification

antisense

Length

256 nt

Genomic location

chr5+:149829002..149829258

Exon number

1

Exons

149829002..149829258

Genome context

Sequence
000001 GCCGTATTGC GGGGCCGAGG CCTTAAAAGG CTGGACCCGC ACTCACCCTT ACTTCACAAG CTCCTCCCTG AAAGCAAAAC 000080
000081 GGGCCTTCTG AGACCAGGAA CGAACTCAAT CCCGAGTTGG CCAGGATCCA GGTGGGCCAG CCGCGCGTCT CTTGCCCGGC 000160
000161 ACCTAGCTCG GTTCCCACGG AAAGACCCCC GTCTCTCGTC CCAAGCCCCA CAGGGTCCCC TCGCCGCAGG ATGCCCCCCG 000240
000241 ATTGTCGCGC CCGGGC
[back to top]